Gjølberg, Torleif Tollefsrud http://orcid.org/0000-0002-1719-7677
Frick, Rahel http://orcid.org/0000-0002-3469-5686
Mester, Simone
Foss, Stian
Grevys, Algirdas
Høydahl, Lene Støkken
Jørstad, Øystein Kalsnes
Schlothauer, Tilman http://orcid.org/0000-0001-5844-4438
Sandlie, Inger
Moe, Morten C. http://orcid.org/0000-0002-0615-804X
Andersen, Jan Terje http://orcid.org/0000-0003-1710-1628
Funding for this research was provided by:
Norges Forskningsråd (274993)
Article History
Received: 11 May 2022
Accepted: 1 August 2022
First Online: 18 August 2022
Competing interests
: M.C.M. has been a member of advisory boards at Bayer, Novartis, Roche and Allergan and has received lecture fees from Bayer and Roche. Ø.K.J. has been member of Bayer, Allergan and Roche advisory boards and has received lecture fees from Bayer and Allergan. The remaining authors declare no competing interests.